Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-19

FDA Approved: FINGOLIMOD — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Ascend Laboratories, LLC's supplemental application for fingolimod hydrochloride (generic fingolimod), expanding access for treating multiple scler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod hydrochloride (Fingolimod hydrochloride)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE)